Literature DB >> 21053101

Diversity of axin in signaling pathways and its relation to colorectal cancer.

Nighat Parveen1, Mahboob Ul Hussain, Arshad A Pandith, Syed Mudassar.   

Abstract

Colorectal cancer is one of the commonest cancers in western world, while majority of cases of CRC are sporadic, a significant minority occurs as a result of inherited genetic mutations. Various studies have demonstrated that tumorigenesis of colon arises as a result of accumulation of multiple genetic alterations targeting the single signal transduction pathway. Genetic alteration of axin has been implicated in different cancers including colorectal cancers. Axin being a multidomain protein interacts with multiple proteins and acts as major scaffold protein in signaling pathways like c-jun/SAPK, TGF-β, and Wnt. In different signaling pathways, axin utilizes different domains and hence exerts distinct roles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053101     DOI: 10.1007/s12032-010-9722-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  82 in total

1.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

2.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.

Authors:  D Yan; M Wiesmann; M Rohan; V Chan; A B Jefferson; L Guo; D Sakamoto; R H Caothien; J H Fuller; C Reinhard; P D Garcia; F M Randazzo; J Escobedo; W J Fantl; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 4.  Smads: transcriptional activators of TGF-beta responses.

Authors:  R Derynck; Y Zhang; X H Feng
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

5.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

6.  The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals.

Authors:  C A Cowan; M Henkemeyer
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

7.  Identification of DCAP, a drosophila homolog of a glucose transport regulatory complex.

Authors:  Hiroto Yamazaki; Roel Nusse
Journal:  Mech Dev       Date:  2002-11       Impact factor: 1.882

8.  Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance?

Authors:  Michael J O'brien; Sidney J Winawer; Ann G Zauber; Marijayne T Bushey; Stephen S Sternberg; Leonard S Gottlieb; John H Bond; Jerome D Waye; Melvin Schapiro
Journal:  Clin Gastroenterol Hepatol       Date:  2004-10       Impact factor: 11.382

9.  I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.

Authors:  Shuichi Kusano; Nancy Raab-Traub
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.

Authors:  F Fagotto; E h Jho; L Zeng; T Kurth; T Joos; C Kaufmann; F Costantini
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

View more
  6 in total

Review 1.  Alternative splicing within the Wnt signaling pathway: role in cancer development.

Authors:  B Sumithra; Urmila Saxena; Asim Bikas Das
Journal:  Cell Oncol (Dordr)       Date:  2016-01-13       Impact factor: 6.730

Review 2.  Wnt/beta-catenin signaling and small molecule inhibitors.

Authors:  Andrey Voronkov; Stefan Krauss
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.

Authors:  Xiuying Shi; Yang Zhao; Chuifeng Fan
Journal:  J Cell Mol Med       Date:  2018-11-12       Impact factor: 5.310

4.  SignaLink 2 - a signaling pathway resource with multi-layered regulatory networks.

Authors:  Dávid Fazekas; Mihály Koltai; Dénes Türei; Dezső Módos; Máté Pálfy; Zoltán Dúl; Lilian Zsákai; Máté Szalay-Bekő; Katalin Lenti; Illés J Farkas; Tibor Vellai; Péter Csermely; Tamás Korcsmáros
Journal:  BMC Syst Biol       Date:  2013-01-18

Review 5.  Tankyrases: structure, function and therapeutic implications in cancer.

Authors:  Teemu Haikarainen; Stefan Krauss; Lari Lehtio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma.

Authors:  Guilherme Muniz Bourroul; Hélio José Fragoso; José Walter Feitosa Gomes; Vivian Sati Oba Bourroul; Celina Tizuko Fujiyama Oshima; Thiago Simão Gomes; Gabriela Tognini Saba; Rogério Tadeu Palma; Jaques Waisberg
Journal:  Einstein (Sao Paulo)       Date:  2016 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.